• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢不健康的个体,无论是否肥胖,其发生严重 2019 冠状病毒病结局的风险均高于代谢健康且不肥胖的个体。

Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.

出版信息

Metabolism. 2022 Mar;128:154894. doi: 10.1016/j.metabol.2021.154894. Epub 2021 Sep 30.

DOI:10.1016/j.metabol.2021.154894
PMID:34600905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8482539/
Abstract

BACKGROUND

This study aimed to determine the relative and independent contributions of impaired metabolic health and obesity to critical coronavirus disease 2019 (COVID-19).

METHODS

We analyzed 4069 COVID-19 patients between January and June 2020 in South Korea, classified into four groups according to metabolic health status and body mass index (BMI): metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy obesity (MHO), and metabolically unhealthy obesity (MUO). The primary outcome was a composite of intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), extracorporeal membrane oxygenation (ECMO), and death. Multivariable Cox proportional hazard regression models were used to estimate the hazard ratio (HR) for the outcome.

RESULTS

The incidence rate (per 100 person-months) of critical COVID-19 was the lowest in the MHNW group (0.90), followed by the MHO (1.64), MUNW (3.37), and MUO (3.37) groups. Compared with MHNW, a significantly increased risk of critical COVID-19 was observed in MUNW (HR, 1.41; 95% CI, 1.01-1.98) and MUO (HR, 1.77; 95% CI, 1.39-2.44) but not in MHO (HR, 1.48; 95% CI, 0.98-2.23). The risk of ICU admission or IMV/ECMO was increased only in MUO; however, the risk of death was significantly higher in MUNW and MUO. The risk of critical COVID-19 increased insignificantly by 2% per 1 kg/m BMI increase but significantly by 13% per 1 metabolically unhealthy component increase, even after mutually adjusting for BMI and metabolic health status.

CONCLUSIONS

Metabolic health is more important to COVID-19 outcomes than obesity itself, suggesting that metabolic health status should be considered for a precise and tailored management of COVID-19 patients.

摘要

背景

本研究旨在确定代谢健康受损和肥胖对重症新型冠状病毒肺炎(COVID-19)的相对和独立影响。

方法

我们分析了 2020 年 1 月至 6 月期间韩国的 4069 例 COVID-19 患者,根据代谢健康状况和体重指数(BMI)将其分为四组:代谢健康正常体重(MHNW)、代谢不健康正常体重(MUNW)、代谢健康肥胖(MHO)和代谢不健康肥胖(MUO)。主要结局是重症监护病房(ICU)入院、有创机械通气(IMV)、体外膜氧合(ECMO)和死亡的复合结局。多变量 Cox 比例风险回归模型用于估计结局的风险比(HR)。

结果

在 MHNW 组,重症 COVID-19 的发生率(每 100 人月)最低(0.90),其次是 MHO(1.64)、MUNW(3.37)和 MUO(3.37)组。与 MHNW 相比,MUNW(HR,1.41;95%CI,1.01-1.98)和 MUO(HR,1.77;95%CI,1.39-2.44)发生重症 COVID-19 的风险显著增加,但 MHO 组(HR,1.48;95%CI,0.98-2.23)并非如此。只有 MUO 组 ICU 入院或 IMV/ECMO 的风险增加,而 MUNW 和 MUO 组的死亡风险显著更高。BMI 每增加 1kg/m2,重症 COVID-19 的风险增加 2%,但代谢不健康成分每增加 1 个,风险增加 13%,即使在相互调整 BMI 和代谢健康状况后也是如此。

结论

代谢健康对 COVID-19 结局的重要性超过肥胖本身,这表明代谢健康状况应考虑用于 COVID-19 患者的精准和定制化管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c5d/8482539/199c72115fcf/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c5d/8482539/199c72115fcf/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c5d/8482539/199c72115fcf/gr1_lrg.jpg

相似文献

1
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.代谢不健康的个体,无论是否肥胖,其发生严重 2019 冠状病毒病结局的风险均高于代谢健康且不肥胖的个体。
Metabolism. 2022 Mar;128:154894. doi: 10.1016/j.metabol.2021.154894. Epub 2021 Sep 30.
2
Association between metabolic overweight/obesity phenotypes and readmission risk in patients with lung cancer: A retrospective cohort study.代谢性超重/肥胖表型与肺癌患者再入院风险之间的关联:一项回顾性队列研究。
EClinicalMedicine. 2022 Jul 22;51:101577. doi: 10.1016/j.eclinm.2022.101577. eCollection 2022 Sep.
3
Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?体重正常的成年人的代谢不健康表型:与肥胖成年人相比,其心脏代谢健康状况是否更差?
Obes Res Clin Pract. 2023 Mar-Apr;17(2):116-121. doi: 10.1016/j.orcp.2023.02.001. Epub 2023 Feb 20.
4
Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China.随着时间推移的代谢体重表型变化模式:中国应用多状态马尔可夫模型的纵向研究。
Front Public Health. 2022 Dec 15;10:1026751. doi: 10.3389/fpubh.2022.1026751. eCollection 2022.
5
Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.代谢异常而非肥胖本身与台湾人群的慢性肾脏病相关。
Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):418-425. doi: 10.1016/j.numecd.2019.09.029. Epub 2019 Oct 8.
6
Associations between metabolic overweight/obesity phenotypes and mortality risk among patients with chronic heart failure.代谢超重/肥胖表型与慢性心力衰竭患者死亡风险之间的关系。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1445395. doi: 10.3389/fendo.2024.1445395. eCollection 2024.
7
Early prediction of body composition parameters on metabolically unhealthy in the Chinese population via advanced machine learning.基于先进机器学习的中国人群代谢不健康状态下人体成分参数的早期预测。
Front Endocrinol (Lausanne). 2023 Aug 29;14:1228300. doi: 10.3389/fendo.2023.1228300. eCollection 2023.
8
Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population.代谢健康型超重/肥胖与代谢不健康型和正常体重的动态变化与 2 型糖尿病风险:一项中国农村成年人的队列研究。
Obes Res Clin Pract. 2018 Jan-Feb;12(1):61-71. doi: 10.1016/j.orcp.2017.10.005. Epub 2017 Oct 31.
9
The Presence of Urinary Ketones according to Metabolic Status and Obesity.根据代谢状态和肥胖情况存在尿酮体。
J Korean Med Sci. 2020 Aug 10;35(31):e273. doi: 10.3346/jkms.2020.35.e273.
10
Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study.代谢健康的肥胖人群患糖尿病和心血管疾病的风险:韩国基因组与流行病学研究
Medicine (Baltimore). 2016 Apr;95(15):e3384. doi: 10.1097/MD.0000000000003384.

引用本文的文献

1
Metabolic health is more strongly associated with the severity and mortality of coronavirus disease 2019 than obesity.代谢健康与2019冠状病毒病的严重程度和死亡率的关联比肥胖更为密切。
Arch Public Health. 2024 Aug 23;82(1):131. doi: 10.1186/s13690-024-01372-8.
2
Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus.高瘦素血症作为类风湿关节炎和系统性红斑狼疮女性各种肥胖和超重表型的标志物。
Dokl Biochem Biophys. 2024 Aug;517(1):182-194. doi: 10.1134/S1607672924700893. Epub 2024 Jun 10.
3
Strong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome.
代谢综合征正常体重受试者中代谢参数与不对称二甲基精氨酸(ADMA)和血管细胞黏附分子-1(VCAM-1)的强关联
Diabetes Metab Syndr Obes. 2024 Feb 19;17:833-839. doi: 10.2147/DMSO.S448650. eCollection 2024.
4
Diabetes Mellitus, Energy Metabolism, and COVID-19.糖尿病、能量代谢与 COVID-19
Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032.
5
Metabolic Unhealthiness is Associated With Increased Risk of Critical COVID-19 Pneumonia and Inpatient Mortality in Hospitalized Patients with Obesity or Overweight.代谢不健康与肥胖或超重住院患者发生重症 COVID-19 肺炎及住院死亡率增加相关。
Cureus. 2023 Jul 20;15(7):e42205. doi: 10.7759/cureus.42205. eCollection 2023 Jul.
6
Repurposing Metformin for Vascular Disease.二甲双胍在血管疾病中的再利用。
Curr Med Chem. 2023;30(35):3955-3978. doi: 10.2174/0929867329666220729154615.
7
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.肥胖与 COVID-19 严重程度和死亡率的关联:一项更新的系统评价、荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2022 Jun 3;13:780872. doi: 10.3389/fendo.2022.780872. eCollection 2022.
8
Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review.肥胖症的表型分析及其饮食和药物治疗进展:叙述性综述
Front Nutr. 2022 Feb 15;9:804719. doi: 10.3389/fnut.2022.804719. eCollection 2022.
9
Editorial: Obesity, metabolic phenotypes and COVID-19.社论:肥胖、代谢表型与2019冠状病毒病
Metabolism. 2022 Mar;128:155121. doi: 10.1016/j.metabol.2021.155121. Epub 2022 Jan 10.